• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种三价即用型猪圆环病毒2a疫苗在断奶仔猪中的有效性和安全性

Efficacy and Safety of a Tri-Valent Ready-to-Use Porcine Circovirus Type 2a, and Vaccine in Weaned Pigs.

作者信息

Allen Michelle, Roerink Frank, Crowley Abigail, Knetter Susan, Morgan Chandra, Wei Huiling, Segers Ruud

机构信息

Intervet Inc. (d/b/a Merck Animal Health), De Soto, KS 66018, USA.

Intervet International B.V., 5831 AN Boxmeer, The Netherlands.

出版信息

Vaccines (Basel). 2025 Jun 25;13(7):681. doi: 10.3390/vaccines13070681.

DOI:10.3390/vaccines13070681
PMID:40733658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12299040/
Abstract

: This study describes multiple trials demonstrating the safety and efficacy of a tri-valent vaccine against diseases caused by Porcine Circovirus Types 2a and 2d (PCV2a, PCV2d), , and . : For each of the PCV2a and PCV2d onset of immunity (OOIs) and duration of immunity (DOI) studies, 25 pigs were vaccinated with a tri-valent vaccine and 25 with placebo. After dual challenge with PCV2a and porcine reproductive and respiratory virus (PRRSV) (OOI) or single challenge with PCV2d (OOI and DOI), respectively, viremia and lymphoid depletion data were collected. For each of the OOI and DOI studies, 35 to 70 pigs were vaccinated with the tri-valent vaccine and 35 to 70 with placebo. After challenge, the lungs were scored for disease. For the OOI study, 40 to 50 pigs were vaccinated with the tri-valent and 40 to 50 with placebo. After challenge, the intestines were scored for disease. All pigs were vaccinated at approximately 3 weeks of age, and all placebo vaccines were product matched. : Vaccinating pigs with a tri-valent vaccine reduced viremia and lymphoid depletion due to PCV2a and PCV2d, reduced lung lesions due to and reduced ileum and colonization scores due to . : The trials reported here demonstrated the safety and efficacy of the first ready-to-use PCV2, , and vaccine for pigs.

摘要

本研究描述了多项试验,这些试验证明了一种三价疫苗对由2a型和2d型猪圆环病毒(PCV2a、PCV2d)引起的疾病的安全性和有效性。对于PCV2a和PCV2d的每项免疫起始(OOI)和免疫持续时间(DOI)研究,25头猪接种三价疫苗,25头接种安慰剂。分别在用PCV2a和猪繁殖与呼吸综合征病毒(PRRSV)进行双重攻毒(OOI)或用PCV2d进行单次攻毒(OOI和DOI)后,收集病毒血症和淋巴组织耗竭数据。对于每项OOI和DOI研究,35至70头猪接种三价疫苗,35至70头接种安慰剂。攻毒后,对肺部疾病进行评分。对于OOI研究,40至50头猪接种三价疫苗,40至50头接种安慰剂。攻毒后,对肠道疾病进行评分。所有猪均在约3周龄时接种疫苗,所有安慰剂疫苗均与产品匹配。给猪接种三价疫苗可减少由PCV2a和PCV2d引起的病毒血症和淋巴组织耗竭,减少由[未提及病毒名称]引起的肺部病变,并减少由[未提及病毒名称]引起的回肠病变和定植评分。此处报告的试验证明了首款即用型PCV2[此处原文似乎有缺失内容]疫苗对猪的安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/6f733e11aafb/vaccines-13-00681-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/165a32c32b03/vaccines-13-00681-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/f8c74a978608/vaccines-13-00681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/3e0ec59aa948/vaccines-13-00681-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/fbab911d5ee8/vaccines-13-00681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/013b32e7535a/vaccines-13-00681-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/8a4041ffa157/vaccines-13-00681-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/6f733e11aafb/vaccines-13-00681-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/165a32c32b03/vaccines-13-00681-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/f8c74a978608/vaccines-13-00681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/3e0ec59aa948/vaccines-13-00681-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/fbab911d5ee8/vaccines-13-00681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/013b32e7535a/vaccines-13-00681-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/8a4041ffa157/vaccines-13-00681-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f6/12299040/6f733e11aafb/vaccines-13-00681-g007a.jpg

相似文献

1
Efficacy and Safety of a Tri-Valent Ready-to-Use Porcine Circovirus Type 2a, and Vaccine in Weaned Pigs.一种三价即用型猪圆环病毒2a疫苗在断奶仔猪中的有效性和安全性
Vaccines (Basel). 2025 Jun 25;13(7):681. doi: 10.3390/vaccines13070681.
2
A field evaluation of a new porcine circovirus type 2d and Mycoplasma hyopneumoniae bivalent vaccine in herds suffering from subclinical PCV2d infection and enzootic pneumonia.一种新型猪圆环病毒 2 型和支原体肺炎二价疫苗在亚临床 PCV2d 感染和地方性肺炎猪群中的田间评估。
Vet Med Sci. 2024 Sep;10(5):e70001. doi: 10.1002/vms3.70001.
3
Non-Compromised Efficacy of the First Commercial Ready-to-Use Genotype 2d Porcine Circovirus Type 2 and Vaccine.首款商业化即用型2d型猪圆环病毒2型疫苗的疗效不受影响。
Viruses. 2025 Apr 11;17(4):554. doi: 10.3390/v17040554.
4
Experimental efficacy of a trivalent vaccine containing porcine circovirus types 2a/b (PCV2a/b) and Mycoplasma hyopneumoniae against PCV2d and M. hyopneumoniae challenges.含猪圆环病毒 2 型(PCV2a/b)和猪肺炎支原体的三价疫苗对 PCV2d 和 M. hyopneumoniae 挑战的实验疗效。
Vet Microbiol. 2021 Jul;258:109100. doi: 10.1016/j.vetmic.2021.109100. Epub 2021 May 4.
5
Effect of yeast probiotics in lactation and yeast cell wall prebiotic and Bacillus subtilis probiotic in nursery on lifetime growth performance, immune response, and carcass characteristics.酵母益生菌对哺乳期和酵母细胞壁益生元和枯草芽孢杆菌益生菌对育肥期生长性能、免疫反应和胴体特性的影响。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae320.
6
Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.评估三联疫苗混合物对支原体、猪圆环病毒 2 型和猪繁殖与呼吸综合征病毒三重挑战的疗效,以及各单价疫苗对单一挑战的疗效比较。
BMC Vet Res. 2019 Oct 16;15(1):342. doi: 10.1186/s12917-019-2091-6.
7
Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and monovalent and bivalent vaccines against a dual challenge.商品猪圆环病毒 2 型(PCV2)疫苗与单价及双价疫苗对双重挑战的效果比较。
Can J Vet Res. 2020 Oct;84(4):272-282.
8
Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and against a dual PCV2d and challenge.一种含2d型猪圆环病毒的新型二价疫苗针对2d型猪圆环病毒和[此处原文缺失内容]双重感染的效力。
Front Vet Sci. 2023 Jul 26;10:1176091. doi: 10.3389/fvets.2023.1176091. eCollection 2023.
9
A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.基于猪圆环病毒 2 型 b 亚型(PCV2b)的实验性疫苗在 PCV2b-支原体肺炎混合感染猪模型中有效。
Vaccine. 2019 Oct 16;37(44):6688-6695. doi: 10.1016/j.vaccine.2019.09.029. Epub 2019 Sep 16.
10
Pathogenicity of Porcine Circovirus Type 2d (PCV2d) in Pigs Infected with PCV2d or Co-infected with Mycoplasma hyopneumoniae and PCV2d or with Porcine Reproductive and Respiratory Syndrome Virus and PCV2d.猪圆环病毒 2d 型(PCV2d)在感染 PCV2d 或与支原体肺炎和 PCV2d 或猪繁殖与呼吸综合征病毒和 PCV2d 混合感染的猪中的致病性。
J Comp Pathol. 2021 Aug;187:75-82. doi: 10.1016/j.jcpa.2021.07.004. Epub 2021 Aug 13.

本文引用的文献

1
Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d.评估新型重组猪圆环病毒 2d 型(PCV2d)疫苗在自然感染 PCV2d 的猪中的效果。
Vaccine. 2021 Jan 15;39(3):529-535. doi: 10.1016/j.vaccine.2020.12.013. Epub 2020 Dec 18.
2
Genetic diversity and prevalence of porcine circovirus type 3 (PCV3) and type 2 (PCV2) in the Midwest of the USA during 2016-2018.2016-2018 年美国中西部地区猪圆环病毒 3 型(PCV3)和 2 型(PCV2)的遗传多样性和流行情况。
Transbound Emerg Dis. 2020 May;67(3):1284-1294. doi: 10.1111/tbed.13467. Epub 2020 Jan 16.
3
Immune response and protection against Lawsonia intracellularis infections in pigs.
猪对胞内劳森菌感染的免疫反应及保护作用。
Vet Immunol Immunopathol. 2020 Jan;219:109959. doi: 10.1016/j.vetimm.2019.109959. Epub 2019 Oct 31.
4
Ongoing challenges posed by the infection dynamics of porcine circovirus 2.猪圆环病毒2型感染动态带来的持续挑战。
Vet Rec. 2019 Feb 9;184(6):186-188. doi: 10.1136/vr.l211.
5
Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy.多抗原重组亚单位疫苗抗猪增生性肠病的病因——细胞内罗松尼亚。
Vaccine. 2019 Feb 28;37(10):1340-1349. doi: 10.1016/j.vaccine.2019.01.029. Epub 2019 Jan 30.
6
Metabolic adaptation of pigs to a Mycoplasma hyopneumoniae and Lawsonia intracellularis dual challenge.猪对支原体肺炎和细胞内劳森菌双重感染的代谢适应。
J Anim Sci. 2018 Jul 28;96(8):3196-3207. doi: 10.1093/jas/sky220.
7
Impact of Mycoplasma hyopneumoniae and Lawsonia intracellularis on the performance of pigs divergently selected for feed efficiency.支原体肺炎和细胞内劳森菌对饲料效率不同选育猪生产性能的影响。
J Anim Sci. 2018 Mar 6;96(2):462-472. doi: 10.1093/jas/skx074.
8
A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.一种针对劳森氏内皮细胞菌的新型灭活疫苗可快速诱导体液免疫,减少细菌脱落,并提供强大的肠道屏障功能。
Vaccine. 2018 Mar 7;36(11):1500-1508. doi: 10.1016/j.vaccine.2017.12.049. Epub 2018 Jan 11.
9
immunology and viral evolution.免疫学与病毒进化
Porcine Health Manag. 2015 Nov 19;1:17. doi: 10.1186/s40813-015-0012-z. eCollection 2015.
10
PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the U.S. during 2014-2016.PCV2d-2是2014年至2016年期间在美国采集的猪样本中PCV2 DNA的主要类型。
Vet Microbiol. 2016 Dec 25;197:72-77. doi: 10.1016/j.vetmic.2016.11.009. Epub 2016 Nov 11.